The headline numbers for Xylem (XYL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Xylem (XYL) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.09 per share a year ago.
Beyond analysts' top-and-bottom-line estimates for Xylem (XYL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
I rate Xylem a buy, driven by secular water scarcity, aging infrastructure, and PFAS treatment themes that ensure durable, non-discretionary demand. XYL's 80/20 transformation is already delivering tangible margin gains, with further upside from the Evoqua integration and PFAS funding pipeline. Despite near-term softness in some segments and tariff headwinds, XYL's long-term growth is underpinned by resilient end markets and internal self-help levers.
Xylem (XYL) reported earnings 30 days ago. What's next for the stock?
XYL gains from strength across end markets, robust backlog level and the acquisition of Evoqua. However, rising operating costs and expenses might dent its margins.
Xylem Inc. (NYSE:XYL ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Keith Buettner - Vice President, Investor Relations & Financial Planning & Analysis Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Baird Scott Davis - Melius Research Nathan Jones - Stifel Saree Boroditsky - Jefferies Bryan Blair - Oppenheimer Joe Giordano - TD Cowen Operator Good day, and welcome to Xylem's First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
XYL's first-quarter 2025 revenues increase 2% year over year, driven by the impressive performances of its Water Infrastructure and Measurement & Control units.
The headline numbers for Xylem (XYL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Xylem (XYL) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.90 per share a year ago.
Xylem is now a $27 billion (by market cap) major player in water technology. To date, XYL increased its dividend for 15 consecutive years, with a 10-year dividend growth rate of 10.9%. With the payout ratio sitting at 43.8%, Xylem has plenty of dividend firepower in order to keep that low-double-digit dividend growth coming.
XYL's Q1 results are likely to gain from strength in M&CS and Water Infrastructure units. Weakness in the Applied Water unit and input cost inflation are likely to have been spoilsports.